Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,377.60
(
-1.44%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
106.55
(
2.27%
)
Bitcoin
80,416.46
(
-0.79%
)
News Focus
News Focus
Post# of 257566
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122982
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 67271

Friday, 10/10/2008 7:05:29 PM

Friday, October 10, 2008 7:05:29 PM

Post# of 257566
Good article, but readers should examine #msg-30789679 for the counterpoint argument.

Also, there are a couple of factual inaccuracies in the article: i) I don’t think it’s correct to say that King has “removed” bovine factor V from Thrombin-JMI; and ii) GTCB is no longer planning to develop recombinant albumin, although the technology to make it in transgenic cows has been shown to work.

Thanks for posting the article. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today